(Axios) – Weight-loss surgery is more cost-effective than taking blockbuster GLP-1 drugs, delivering two more healthy years of life and saving patients about $9,000 a year, according to a new analysis. Why it matters: Such side-by-side comparisons could be critical to insurers’ coverage decisions as demand for drugs such as Ozempic and Wegovy surges. (Read More)